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In Vivo Depletion of CD11c Dendritic Cells
Abrogates Priming of CD8 T Cells
by Exogenous Cell-Associated Antigens
lymphocytes, due in large part to the successful applica-
tion of gene targeting strategies. Moreover, mice ren-
dered deficient for lymphocyte subsets by ablation of
the respective antigen receptors have become standard
tools in immunological studies. In contrast, the acces-
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Infected nonhematopoietic cells are, however, incom-
petent to initiate a MHC class I-restricted CTL response
Introduction (Lenz et al., 2000; Sigal et al., 1999). Immunosurveillance
for intracellular pathogens hence requires sensitivity to
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gen resulting in “cross-presentation” on APC was sub-
sequently demonstrated for viral proteins, tumor anti-
gens, and protein-coated spleen cells (for references
see Heath and Carbone, 2001).
All three BM-derived APC, i.e., macrophages, DC, and
B lymphocytes, have been reported to be competent to
present class I-restricted exogenously derived antigens
in vitro (for references see Heath and Carbone, 2001).
In vitro presentation of exogenous cellular material, i.e.,
cross-presentation, has been demonstrated for macro-
phages and DC (Albert et al., 1998; Bellone et al., 1997).
Macrophages are, however, poor stimulators of T cells
in vitro (Steinman and Cohn, 1973).
In vivo, CTL-cross-priming persists in the absence of
B cells (Schoenberger et al., 1998) but is abrogated
by depletion of phagocytes (Debrick et al., 1991). This
finding led originally to the interpretation that macro-
phages are the cross-priming APC (Debrick et al., 1991).
However, “immature” DC are also highly effective in
uptake of exogenous antigen (for references see
Steinman and Swanson, 1995). The identity of the
phagocyte responsible for in vivo cross-priming has
therefore remained unclear. More recently, Kurts et al.
reported that transgenic DC-restricted MHC class I ex-
pression restores in vivo cross-presentation in MHC
class I-deficient mice (Kurts et al., 2001). While this find-
Figure 1. Phenotypic Characterization of DTR Transgenic Mice
ing establishes that DC are sufficient for in vivo cross-
(A) Schematic representation of the DTR/GFP transgene.
priming, it remains unknown whether the two mononu- (B) Flow cytometric analysis of spleen cells of DTR transgenic (line
clear phagocyte subsets, i.e., macrophages and DC, are 57) and nontransgenic FVB/N mice indicating GFP expression in
functionally redundant with respect to CTL priming. CD11c DC. Histograms show GFP expression in CD8 and CD8
DC subsets. Histogram gates are indicated in the dot plot. OpenHere, we report a novel diphtheria toxin-based system
histograms, wild-type cells; filled histograms, DTR transgenic cells.that allows the inducible in vivo ablation of dendritic
Dead cells were excluded by propidium iodide (PI) staining.cells. We demonstrate an essential in vivo role for
CD11c DC, as the depletion of these cells abrogates
the priming of CTL precursors in immune responses to
cell-associated antigens (cross-priming). The physio-
from the low affinity of the toxin for the rodent hbEGF.logical relevance of this finding is underlined by the fact
Transfer of a primate DTR into mice via transgenesisthat in vivo DC depletion impairs the establishment of
hence confers DT sensitivity to murine cells. SpecificityCTL responses to infection with the intracellular bacte-
and timing of cell ablation can be determined by cellrium Listeria monocytogenes and the murine Malaria
type-restricted promoter/enhancer elements and by theparasite Plasmodium yoelii.
regimen of the toxin administration, respectively. A simi-
lar conditional ablation strategy was recently used toResults
study hepatocyte function (Saito et al., 2001).
To target DT sensitivity to DC, we generated mice thatA Mouse Model for Inducible In Vivo DC Ablation
carry a transgene encoding a simian DTR-GFP (greenTo probe for essential DC functions in the intact animal
fluorescent protein) fusion protein under control of thewhile avoiding the complicating issue of the develop-
murine CD11c promoter (Brocker et al., 1997) (Figuremental interdependence of the DC and T cell pools, we
1A). CD11c encodes a subunit of the CD11c/CD18 have generated a mouse model that allows conditional
integrin. All murine DC subsets express CD11c exceptablation of DC. Our strategy is based on the fact that
for CD11cnegative-low epidermal Langerhans’ (LH) cells thatmurine cells, unlike primate cells, are insensitive to kill-
upregulate CD11c expression upon maturation. Murineing by diphtheria toxin (DT) (Pappenheimer et al., 1982).
CD11c expression is largely restricted to the DC com-DT is one of the best studied of all bacterial exotoxins
partment. However, CD11c expression has also been(Holmes, 2000). The cytotoxicity of the heterodimeric DT
reported for activated intraepithelial lymphocytes (IEL)is strictly dependent on receptor-mediated endocytosis.
and CD8 LN T cells (Huleatt and Lefrancois, 1995).DT enters the cell via interaction of its DT B subunit with
All splenic DC of CD11c-DTR transgenic mice werethe cellular DT receptor (DTR), the heparin binding EGF-
fluorescently labeled, with DTR-GFP expression on bothlike growth factor (hbEGF) (Naglich et al., 1992). Upon
the CD8 and the CD8 DC subset (Figure 1B). To inves-endocytosis, the DT A subunit is released and catalyzes
tigate toxin sensitivity, we injected CD11c-DTR trans-ADP-ribosylation of elongation factor 2, resulting in inhi-
genic mice intraperitoneally (i.p.) with 100 ng of DTbition of protein synthesis. As a consequence, DT in-
(about 4 ng DT/g body weight) and analyzed the splenicduces rapid apoptosis in both mitotic and terminally
differentiated cells. DT resistance of murine cells results DC compartment 1 day later. DT injection led to rapid
DC Requirement for In Vivo CTL Priming
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depletion of CD11c DC (Figure 2A). To address whether
other splenic APC populations are affected by the DT
treatment, we determined the splenic APC counts of
CD11c-DTR transgenic mice that had received a single
DT injection. The toxin-induced DC depletion persisted
for 2 days, after which DC numbers were gradually re-
stored (Figure 2B). B cells and F4/80 macrophages,
however, remained unaffected (Figure 2B). DT injection
had no effect on DC populations in nontransgenic lit-
termates (Figure 2A, data not shown). Specificity of the
splenic DC depletion was also confirmed by compara-
tive immunohistochemical analysis of cryosections of
DT-treated nontransgenic and DTR transgenic BALB/c
spleens (see Supplemental Figure S1 at http://www.
immunity.com/cgi/content/full/17/2/211/DC1). Tran-
sient DC depletion was not associated with sign of ill-
ness or long-term defects. Repetitive systemic DT appli-
cation resulted, however, in lethality in DTR-transgenic
mice (data not shown).
In vitro DC depletion experiments using antibody-
mediated complement lysis have shown that splenic DC
are of critical importance as stimulators in a primary
mixed leukocyte reaction (MLR) (Steinman et al., 1983).
We were able to reproduce this observation by in vivo
depletion of splenic DC, providing a demonstration of
the effectiveness of DT-induced DC ablation. We in-
jected DTR transgenic and nontransgenic FVB/N mice
with DT, isolated their spleen cells at 24 hr, and mixed
them with allogeneic C57BL/6 T cells. Splenocytes from
DT-treated nontransgenic mice provided a strong stimu-
lation in the MLR. However, depletion of DC from the
spleen of the CD11c-DTR mice resulted in the complete
loss of in vitro stimulation of alloreactive T cells (Fig-
ure 2C).
DT-induced DC depletion allows us to investigate the
role of DC in in vivo T cell activation. However, in agree-
ment with earlier studies (Huleatt and Lefrancois, 1995),
when activated in vitro or in vivo (via graft-versus host
reaction) a substantial proportion of CD11c-DTR trans-
genic CD8 T cells displayed CD11c promoter activity,
i.e., GFP expression (data not shown). These GFP-posi-
tive CD8 T cells were also DT sensitive (data not
shown). To circumvent this problem, we have used
adoptive transfer of non-DTR transgenic T cells into
CD11c-DTR transgenic mice prior to DT treatment. This
approach has the added advantage of permitting the
use of CFSE-labeled T cell grafts, which allows the moni-
Figure 2. DT Sensitivity of the DC Compartment in DTR Transgenic
toring of T cell priming as the fluorescent dye is diluted Mice
with cell proliferation. We have used the adoptive trans-
(A) Flow cytometric analysis of spleen cells of wt and DTR transgenic
fer approach to study the effect of DC ablation on T cell (line 57) FVB/N mice 24 hr after injection of 100 ng DT or control
activation in the systems described below. vehicle.
(B) Analysis of splenic APC populations of homozygous CD11c-DTR
transgenic mice (line 57) after i.p. injection of 100 ng DT (day 0). DataRequirement of DC for In Vivo Cross-Priming
represent mean of two mice per time point and are representative ofof CD8 T Cells
two independent experiments. B cells are represented by squares
Presentation of exogenous cell-associated antigens and defined as being CD19; macrophages are represented by trian-
(cross-presentation) requires the uptake of the antigen gles and defined as being F4/80; DC are presented by circles and
defined as being CD11c. Open squares represent total splenocyteby phagocytosis. Cross-priming of T cells thus depends
counts. Dot blots below the graph show a representative flow cyto-on the presence of BM-derived mononuclear phago-
metric analysis of two time points.cytes. To investigate the possibility of distinct roles of
(C) Mixed leukocyte reaction with 8  105 stimulator splenocytesmacrophages and DC in this process, we employed a
(FVB/N; H2q) and 105 responder T cells (C57BL/6; H2b). Data are
model system involving the intravenous injection of mice representative of three experiments with similar results. Note that
with syngeneic, MHC class I-deficient spleen cells. the MLR was also abrogated by addition of DT during the culture
resulting in in vitro DC depletion.When the splenocytes are loaded with ovalbumin (Ova),
Immunity
214
Figure 3. DC Dependence of In Vivo CTL
Cross-Priming with Cell-Associated Antigen
(A) Flow cytometric analysis of CFSE-labeled
OT-I CD8 T cell graft (106 cells) in DT-treated
nontransgenic and DTR transgenic (line 11)
C57Bl/6 mice 2 days after immunization with
OVA-loaded 2m/ splenocytes or control
splenocytes loaded with BSA. Histograms
represent cells gated according to scatter,
CD8, and V5 expression as indicated in dot
plots. Note that the large CFSE-negative peak
represents host V 5 CD8 T cells.
(B) Analysis of CFSE-labeled OT-I T cells
(CD45.2, 106 cells) 3 days after immunization
of wt C57Bl/6 (B6.SJL, CD45.1) and MHC
class II-deficient mice (I-Ab /, CD45.1) with
OVA-loaded 2m/ splenocytes. Histo-
grams represent cells gated according to
scatter, expression of CD8, and the allotypic
marker CD45.2 as indicated in dot plots. Dead
cells were excluded by PI staining.
this protocol results in the expansion of Ova-specific scribed (Wang et al., 2001). The results are therefore
consistent with direct impairment of CD8 T cell primingCTL in response to antigen presented by host MHC
class I molecules (den Haan et al., 2000; Moore et al., with cell-associated antigen in DC-depleted mice.
1988). To determine whether DC are required for this in
vivo cross-priming, we analyzed the priming of Ova- Requirement of DC to Elicit Anti-Listeria
CTL Responsesspecific CTL precursors in a DC-depleted spleen. To
this end, we adoptively transferred Ova-specific OT-I To extend the analysis of CD8 T cell priming from re-
sponses against a model antigen to those specific forTCR transgenic T cells (Hogquist et al., 1994) into
CD11c-DTR transgenic and nontransgenic C57BL/6 lit- a microbial pathogen, we chose to examine priming of
T cells by Listeria monocytogenes. This gram-positivetermates. Two days after transfer of the CFSE-labeled
OT-I cells, the animals were treated with DT to deplete microorganism is a facultative intracellular pathogen
that infects macrophages and a wide range of nonpro-DC. Eight hours later, the mice were immunized by i.v.
injection with Ova-loaded MHC-class I-deficient (b2m/) fessional phagocytes (Sheehan et al., 1994). After enter-
ing the eukaryotic cell, L. monocytogenes escapes intosplenocytes. Spleens were isolated 2 days later, and
CFSE-labeled Ova-specific OT-I T cells in the wt and the cytosol, where it secretes proteins that are pro-
cessed by the MHC class I presentation pathway. UponDC-depleted spleens were analyzed for the dilution of
CFSE-label as an indicator of in vivo proliferation. As infection with sublethal doses of bacteria, mice rapidly
clear L. monocytogenes from spleen and liver, resultingshown in Figure 3A, depletion of DC completely abro-
gated the priming of the Ova-specific CTL precursors. in life-long, predominantly CTL-mediated immunity. Pro-
tective host CTL responses are directed against listerialIn some experimental systems, CTL cross-priming
has been reported to be dependent on “licensing” of antigens presented by both classical MHC class Ia and
nonclassical MHC class Ib molecules.the APC by cognate CD4 T cell help (Bennett et al.,
1998; Ridge et al., 1998; Schoenberger et al., 1998). To investigate the role of DC in an immune response
toward the intracellular bacterium, CD11c-DTR trans-However, with the protocol that we used, priming of
OT-I CD8 T cells was unimpaired in CD4 T cell-deficient genic and control BALB/c mice received Listeria-spe-
cific CFSE-labeled CTL precursor grafts isolated frommice (I-Ab/) (Figure 3B). The high CTL-precursor fre-
quencies used in the adoptive transfers thus override WP11.12 TCR transgenic mice. This TCR is directed
against a peptide derived from the p60 protein secretedthe requirement for CD4 T cell help, as previously de-
DC Requirement for In Vivo CTL Priming
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Figure 4. DC Dependence of Classical and
Nonclassical MHC-Restricted Anti-Listeria
CTL Responses
(A) Flow cytometric analysis of splenocyte of
nontransgenic and DTR transgenic (line 57)
littermate BALB/c mice 10 hr after DT injec-
tion (4 ng/g body weight).
(B) Flow cytometric analysis of CFSE-labeled
WP11.12 CD8 T cell graft (106 cells) in DT-
treated nontransgenic and DTR transgenic
(line 57) BALB/c mice 4 days after i.v. injection
of 2000 live L. monocytogenes. Histograms
represent cells gated according to scatter,
CD8, and V 8 expression as indicated in dot
plots. Note that the large CFSE peak repre-
sents host V 8 CD8 T cells. Dead cells were
excluded by PI staining.
(C) Flow cytometric analysis of CFSE-labeled
C10.4 CD8 T cell graft (Thy1.1, 106 cells) in
spleens of DT-treated DTR transgenic (line
57) and nontransgenic littermate CB6F1 mice
(Thy1.2) 4 days after i.v. injection of 2000 live
L. monocytogenes. Histograms represent
cells gated according to scatter, CD8, and
Thy1.1 expression as indicated in dot plots.
Dead cells were excluded by PI staining.
by L. monocytogenes into the cytosol of infected cells presented fM peptide derived from a mitochondrial
NADH dehydrogenase subunit (Berg et al., 1999).(Mercado et al., 2000). One day after CD8 T cell transfer,
the recipient mice were treated with DT, which resulted CD11c-DTR transgenic and nontransgenic control re-
cipient mice were treated with DT and inoculated within depletion of splenic DC at 10 hr in the DTR transgenic
mice (Figure 4A). Eight hours after DT treatment, the 2000 live L. monocytogenes. Anti-Listeria responses
were assessed 4 days after infection. As shown in Figuremice were infected intravenously with 2000 live L. mono-
cytogenes. Four days after the infection, we analyzed 4C, DC depletion completely abrogated the in vivo prolif-
erative response of H2-M3-restricted CTL precursors.the in vivo proliferative response of CFSE-labeled TCR
transgenic T cells isolated from the spleen. Whereas Macrophages, the primary targets of L. monocyto-
genes, are considered “professional” BM-derived APC.infection with L. monocytogenes resulted in extensive
proliferation of the TCR transgenic T cells in DT-treated Their failure to initiate anti-Listeria CTL responses in
the absence of DC is therefore surprising. DT treatmentcontrol recipient mice, there was no proliferation ob-
served in DT-treated DTR transgenic animals (Figure does not lead to depletion of splenic macrophages (see
Figure 2B). To rule out the possibility that DC depletion4B). The anti-Listeria CTL response was recently shown
to be independent of CD4 T cell help (Lauvau et al., may cause a functional impairment of splenic macro-
phages, we examined two hallmarks of macrophage2001; Hamilton et al., 2001). DC depletion therefore ap-
pears to have a direct effect on the priming of CTL function, i.e., their phagocytic and microbiocidal activity.
We isolated macrophages from untreated and DC-precursors.
One of the nonclassical MHC-restricted anti-Listeria depleted spleens 10 hr after DT injection, incubated
them in vitro with an attenuated (noninvasive) Shigellaresponses is directed against N-formylated peptides
presented in the context of H2-M3 (Pamer et al., 1992). mutant (BS 176) (Zychlinsky et al., 1992), and determined
uptake and killing of the bacteria over time. As shownThis MHC class Ib-restricted CTL response is sufficient
for Listeria clearance (Seaman et al., 1999) and peaks in Figure 5A, DT-induced in vivo DC depletion affected
neither the efficacy of the bacterial uptake nor the kinet-2 days prior to MHC class Ia-restricted CTL responses
(Kerksiek et al., 1999). To investigate whether DC are ics of the killing by macrophages.
Finally, we investigated whether the failure to mountalso essential for the priming of CTL specific for the
nonclassical H2-M3 molecule, CFSE-labeled CTL pre- a CTL response is due to a defect in presentation of
Listeria-derived peptides in infected DC-depletedcursors isolated from C10.4 TCR transgenic mice were
transferred into recipient mice (Berg et al., 1999). C10.4 spleens. As a read-out for in vivo Listeria-peptide pre-
sentation, we adoptively transferred a prestimulatedmice express a TCR positively selected on a H2-M3
Immunity
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Figure 5. Functionality of Macrophage Com-
partment in DC-Depleted Spleens
(A) In vitro analysis of phagocytic and bacte-
riocidal activity of macrophages isolated from
spleens of two DT-treated DTR transgenic
(line 57) and two nontransgenic littermate
CB6F1 mice. Macrophages isolated by plas-
tic adherence were incubated with the nonin-
vasive Shigella mutant BS176 (at an moi of
1:10). Open bars indicate counts of cell-asso-
ciated and intracellular BS176; black bars in-
dicate counts of phagocytosed BS176; and
dark and light gray bars indicate counts of
BS176 surviving 2 hr and 5 hr inside the mac-
rophages, respectively. Standard deviations
are based on triplicate cultures. FACS blots
below bar diagram show respective spleno-
cyte analysis. Data are representative of two
experiments with similar results.
(B) Flow cytometric analysis of a CFSE-la-
beled WP11.12 CD8 T cell line graft (Thy1.1,
106 cells) in DT-treated nontransgenic and
DTR transgenic (line 57) BALB/c mice
(Thy1.2) 4 days after i.v. injection of 2000 live
L. monocytogenes. Histograms represent
cells gated according to scatter, CD8, and
Thy1.1 expression, as indicated in dot plot.
Stippled histograms represent CFSE-profile
of uninfected wt control. Dead cells were ex-
cluded by PI staining.
CFSE-labeled cytotoxic T cell line generated from anti- 2001). DTR transgenic and nontransgenic control recipi-
ent mice were treated with DT and inoculated 10 hr laterp60 TCR transgenic mice (WP11.12). Depletion of DC
only partially impaired the in vivo restimulation of the T by i.v. injection of 1 105 irradiated P. yoelii sporozoites.
Four days after immunization, we analyzed the fre-cell line (Figure 5B). These data suggest that infected
phagocytes present Listeria-derived peptides in in- quency of anti-sporozoite CTL in the spleens of the
infected mice by staining with a H2-Kd/SYVPSAEQI pep-fected DC-depleted spleens, yet are unable to prime
naive CTL precursors. tide tetramer. Depletion of DC completely abrogated the
expansion of the CTL-precursor graft (Figure 6A). To
investigate effector functions of the primed CTL precur-Requirement of DC to Elicit a CTL Response
against Malaria Liver Stages sors, we determined the frequencies of IFN-producing
peptide-specific cells in the spleens of the wt and DTRtgThe above results provide evidence that DC play a cru-
cial role in the priming of CTL against cell-associated mice by an ELISPOT assay. Circumsporozoite-specific
IFN-producing CTL were readily detected in infectedproteins. To investigate whether the DC requirement
extends to the immune response toward a eukaryotic wt spleens but absent in DT-treated DTRtg mice (Figure
6B). We have previously shown that a sustained CTLpathogen, we decided to study the CTL response to the
rodent parasite Plasmodium yoelii. Malaria sporozoites response to Malaria sporozoites depends on the pres-
ence of CD4 T cells. However, in those studies, CD4are introduced into mammalian hosts via mosquito
bites, enter the bloodstream, and rapidly reach the liver, T cell depletion did not affect the initial phase of the
CD8 response (up to day 4), which is being examinedwhere they invade and proliferate exclusively in hepato-
cytes. Immunization with viable or attenuated malaria here (Carvalho et al., 2002). We therefore conclude that
the impaired CTL response is directly caused by DCsporozoites has been shown to prime CTL capable of
inhibiting the further parasite development in the liver depletion and not by a lack of CD4 T cell help.
(Romero et al., 1989). To study the involvement of DC
in the anti-sporozoite CTL response, we adoptively Discussion
transferred CTL precursors isolated from mice express-
ing a TCR transgene specific for a malaria circumsporo- It is widely believed that dendritic cells are critical for
initiating primary immune responses (Banchereau andzoite protein-derived peptide (SYVPSAEQI) (Sano et al.,
DC Requirement for In Vivo CTL Priming
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Figure 6. DC Dependence of the CTL Re-
sponse to Malaria Sporozoites
(A) Flow cytometric analysis of spleens wt
and DTRtg recipients of anti-sporozoite CTL
precursor grafts 4 days after infection with
Plasmodium yoelii sporozoites. Data are rep-
resentative of three mice per group. All mice
received a single DT injection (4 ng/g body
weight) 10 hr prior to infection. Cells are gated
according to scatter.
(B) ELISPOT assay of splenocytes of non-
transgenic and DTR transgenic (line 57)
BALB/c CTL-precursor recipients 4 days after
infection with Plasmodium yoelii sporozoites.
Black bars, number of sporozoite-peptide
(SYVPSAEQI)-specific IFN-producing cells;
open bars, number of IFN producers in ab-
sence of peptide.
Steinman, 1998). However, while numerous studies have no access to the cytoplasm of infected cells and are
hence excluded from MHC class I presentation in nonhe-demonstrated that antigen-pulsed DC are highly potent
immunostimulators, experimental evidence for a unique matopoietic cells, which therefore fail to be recognized
by CTL. The observed CTL response against these pro-in vivo function of DC has been lacking. In this study,
we describe the use of a DTR-based transgenic system teins thus needed to be elicited by BM-derived APC.
Proteins that are secreted by Listeria into the cytoplasmthat allows the inducible in vivo ablation of DC. As such,
the CD11c-DTR system allowed us for the first time to of infected cells, such as p60, have ready access to
their MHC class I molecules (Shen et al., 1998). Yet, theprobe for essential in vivo DC functions. In the series of
experiments reported in this study, we establish that capacity to prime CTL against these proteins was also
shown to be restricted to a BM-derived APC (Lenz etDC play an essential role in the in vivo priming of CD8
T cells. Furthermore, our finding that DC depletion abro- al., 2000). This APC had to acquire the antigen either
directly via infection or indirectly via cross-presentationgates CTL responses to intracellular pathogens, such as
L. monocytogenes and the malaria parasite Plasmodium of infected apoptotic cells. Here, we show that presenta-
tion of “endogenous” peptides by Listeria-infected mac-yoelii, emphasizes the crucial role of DC for the adaptive
immune defense. rophages fails to initiate a CTL response from naive
CD8 T cell precursors. Our results therefore extend the
previous reports by suggesting that cross-presentationCross-Presentation in the Anti-Listeria CTL Response
We showed in this study that DT-induced DC depletion is essential for the anti-Listeria CTL response. Together
with our experiments with the OVA-loaded cells, thesein CD11c-DTR transgenic mice abrogated classical
and nonclassical MHC-restricted anti-Listeria CTL re- studies identify the cross-priming APC as a CD11c DC.
We therefore interpret the failure to mount anti-Listeriasponses. The question remains as to why the anti-Liste-
ria CTL response is so critically dependent on DC. This CTL responses as a consequence of the abrogation of
an essential cross-presentation step in the priming ofcould be due to a crucial direct uptake of Listeria by
DC. However, DC are, at best, poorly permissive for antibacterial CTL.
Listeria infection (Pron et al., 2001). We therefore favor
the interpretation that the DC requirement results from Cross-Presentation in the CTL Response
to Malaria Parasitesthe dependence of the anti-Listeria CTL response on
cross-presentation. In an elegant study, Shen et al. had DC depletion also abrogated the anti-sporozoite CTL
response against a rodent Malaria parasite. Hepato-previously demonstrated that nonsecreted Listeria anti-
gens efficiently primed CTL responses but, as opposed cytes are the only cells infected by Plasmodium yoelii
sporozoites. Moreover, since only live sporozoites leadto secreted Listeria proteins, failed to confer protection
(Shen et al., 1998). Nonsecreted Listeria proteins have to malaria protection, intrahepatocytic parasites are
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thought to be responsible for parasite immunity. The DC The present study focuses on the potential of DC to
dependence of the anti-circumsporozoite CTL response induce protective CD8 T cell responses, i.e., cross-
therefore strongly suggests that the CTL are primed via priming. However, cross-presentation can also result
cross-presentation of infected hepatocytes. Alterna- in cross-tolerization via deletion or anergy (Heath and
tively, the CTL priming we observe could be due to direct Carbone, 2001). Immature DC are particularly efficient
cross-presentation of the injected sporozoites in the in endocytosis and presentation of apoptotic cells (Al-
spleen. In either case, the capacity for productive cross- bert et al., 1998) and were shown to continuously sample
presentation is restricted to CD11c DC. dying cells in peripheral tissues in vivo (Huang et al.,
2000). Based on these and other findings (Hawiger et
Unique Capacity of CD11c DC to Prime CD8 T Cells al., 2001), DC are currently considered prime candidates
Taken together, our data establish that DC are essential for the induction and maintenance of peripheral toler-
for in vivo CTL cross-priming, i.e., the priming with cell- ance. The ability to induce transient depletion of DC
associated antigens. The immune system is particularly might permit the examination of the role of these cells
sensitive for responding to cell-associated antigens, in the establishment of peripheral tolerance.
presumably because CTL immunity required to monitor
Experimental Proceduresintracellular pathogens is directed against such antigens
(Li et al., 2001). Our findings establish that the ability
Generation of CD11c-DTR Transgenic Miceto sense cell-associated antigens is dependent on the
The transgene encoding the simian diphtheria toxin receptor (DTR)-presence of CD11c DC. Moreover, our results suggest
GFP fusion protein was generated by cloning the PCR-amplified
that the ability to prime naive CD8 T cells is restricted hbEGF cDNA (Genbank accession #M93012, base pair 56–682) as
to CD11c DC. This notion is supported by a recent an EcoRI/ BamHI fragment into pEGFP-N1 (Stratagene). The fused
gene was then PCR amplified and cloned as an EcoRI fragment intoreport demonstrating that only vaccinia virus-infected
CD11c-pDOI-5 (kindly provided by K. Karjalainen [Brocker et al.,DC but not infected macrophages present antigen to
1997]). The transgene fragment was isolated following Not1 diges-naive CD8 T cells in a tissue-draining lymph node (Nor-
tion and injected into the pronuclei of fertilized FVB/N oocytes.bury et al., 2002). Interestingly, CD8 T cell clusters were
Transgenic offspring was screened by Southern blotting. Two trans-
also observed surrounding noninfected DC, suggesting genic lines with homogeneous DC-specific DTR/GFP expression
cross-presentation of virus-infected cells by DC. were established (line DTR#11 and line DTR#57 with transgene copy
Results of in vitro experiments had previously indi- numbers of 1–2 and20, respectively). CD11c-DTR mice were sub-
sequently screened by PCR employing the following primers (DTR1,cated that DC might be superior to macrophages with
5-GCCACCATGAAGCTGCTGCCG-3; DTR2, 5-TCAGTGGGAATTrespect to the presentation of exogenous antigens (Rod-
AGTCATGCC-3). To allow for adoptive transfer experiments,riguez et al., 1999). Furthermore, it was shown that while
CD11c-DTR transgenes were crossed five generations onto the
i.v.-injected cell-associated antigens are rapidly taken BALB/c (line #57) and C57Bl/6 (line #11) background. For systemic
up by all splenic mononuclear phagocytes, upon isola- DC depletion, CD11c-DTR transgenic mice were injected intraperi-
tion only CD11b (CD8) DC but neither CD11b (CD8) toneally with 4 ng/g body weight DT (in PBS; Sigma D-0564, formerly
D-2918).DC nor macrophages were able to cross-prime CTL in
vitro (den Haan et al., 2000). This result could indicate
Adoptive Transfersthat the ability for cross-priming is further restricted.
Ovalbumin-specific CTL precursors carrying a V2/V5 TCR specificHowever, additional studies will be required to define the
for the SIINFEKL peptide presented in the context of MHC class IDC subset harboring the in vivo cross-priming potential.
Kb were isolated from OT-1 mice (Hogquist et al., 1994). MHC class
In light of in vitro results indicating that macrophages Ia-restricted Listeria-specific CTL precursors carrying a V8/V8
are capable of uptake, processing, and presentation of TCR directed against p60449–457 presented in the context of MHC H2-
cell-associated proteins (Heath and Carbone, 2001), it Kd were isolated from WP11.12 mice (Mercado et al., 2000). H2-M3-
restricted CTL precursors were isolated from C10.4 mice (Berg etremains unclear why in the absence of DC they fail to
al., 1999). Malaria sporozoite-specific CTL precursors were isolatedcross-prime CTL in vivo. Only CD11c DC appear able to
from TCR transgenic mice expressing a TCR directed against thepresent cell-associated antigen in immunogenic context
SYVPSAEQI peptide presented in the context of MHC H2-Kd (Sanoto CTL precursors. Alternatively, only CD11c DC might
et al., 2001). T cell grafts were isolated from spleens and LN and
be able to translocate after antigen uptake to a microen- enriched by magnetic depletion of I-Ab B220 non-T cells or posi-
vironment in lymphoid tissue that promotes T cell activa- tive enrichment of CD8 T cells (Miltenyi Biotech). In some experi-
tion. These interpretations assume that the triggering ments, cells were labeled with the intracellular fluorescent dye car-
boxyfluorescein diacetate succimidyl ester (CFSE; Molecularantigen is presented on the DC, a notion supported by
Probes, C-1157) by incubating them in the absence of serum for 8the fact that it is the antigen-presenting capacity of DC
min at RT at 107 cells/ml in 5 M CFSE. CFSE loading was stoppedthat is crucial for in vivo cross-priming (Kurts et al., 2001).
by addition of an equal volume cold FCS. Cells were washed twice inHowever, our results do not exclude the possibility that
complete RPMI medium. 106 clonotype-positive CD8-positive cells
naive T cells encounter cross-presented antigen on a were injected in 200 l of PBS into the tail veins of the recipient
non-DC APC, but DC are essential to support a subse- mice.
quent sustained CTL response.
In vivo depletion of DC results in the loss of the priming FACS Analysis
The staining reagents used in this study included the PE-coupledpotential in a primary mixed leukocyte reaction. It has
antibodies anti-V5 and anti-CD11c; the biotinylated antibodiesbeen previously noted that allogeneic DC present in
anti-F4/80 (Caltag), anti-CD11b, anti-CD11c, and anti V8.1/2; andorgan transplants (albeit at low numbers) could trigger
the APC-coupled antibodies anti-B220, anti-CD11b, and anti-CD8.
allograft rejection (Lechler et al., 2001). DT-treated Unless indicated otherwise, the reagents were obtained from Phar-
CD11c-DTR transgenic mice could therefore be a valu- mingen. Cells were analyzed on a FACS Calibur cytometer or LSR
able source of DC-depleted allografts to further investi- cytometer (Becton-Dickinson, Mountain View, CA) using CellQuest
software (Becton-Dickinson).gate the role of DC in transplant survival.
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